Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous administration of MR and yellow fever vaccines in Japanese adults
jRCT1031210111Completed
- Sponsor
- Grant-in-Aid for Scientific Research
- Start
- May 2021
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine and Measles and Rubella Vaccine (PT Bio Farma) in yellow fever, measles and rubella, sponsored by Grant-in-Aid for Scientific Research. Primary endpoint: Seroprotection rate to yellow fever. Started May 2021; status: completed.
02
Drugs
17D yellow fever vaccineMeasles and Rubella Vaccine (PT Bio Farma)
03
Conditions
yellow fevermeaslesrubella
Beyond the preview
Go deeper on jRCT1031210111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031210111.